ArticleBMC public health2026
Development and psychometric validation of an innovative instrument to assess musculoskeletal disorder prevention behaviors in the petrochemical industry (PREMOVE).
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMusculoskeletal disorders (MSDs) are among the most common occupational health problems and a leading cause of work-related disability, particularly in high-risk industries such as petrochemicals. Preventive behaviors play a crucial role in mitigating MSD risks; however, no validated instrument exists to systematically assess these behaviors in this workforce.
objectiveThis study aimed to develop and psychometrically validate PREMOVE (PREvention of Musculoskeletal Disorders in petrochemical Workers), an innovative instrument designed to evaluate MSD prevention behaviors among petrochemical industry workers, while accounting for occupational and contextual factors influencing preventive practices.
methodsPREMOVE items were generated through qualitative research and unstructured interviews with frontline petrochemical employees to ensure relevance. Expert panels confirmed content and face validity. Construct validity was assessed using exploratory factor analysis (EFA). Reliability was evaluated via internal consistency (Cronbach’s α), test–retest stability (intraclass correlation coefficient, ICC), and convergent validity (Pearson’s r).
resultsOf the 59 initial items, 30 were retained. EFA revealed four dimensions: Educational and Counseling Support, Managerial and Organizational Transformation, Infrastructure Safety and Environmental Redesign, and Necessity of Self-Care. PREMOVE demonstrated high reliability and stability (α = 0.772; ICC = 0.965; r = 0.993).
conclusionsPREMOVE is the first validated, behavior-focused instrument for assessing MSD prevention behaviors in petrochemical workers. It provides a reliable and scientifically robust instrument to guide workplace interventions, support evidence-based decision-making, and enhance occupational health research and safety culture in high-risk industrial settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.